Scanfil: Price and value seem to have found harmony
The overall picture of Scanfil’s Q2 report published on Friday was somewhat neutral relative to the increased expectations, as the company generated a record result in line with our expectations in Q2 and reiterated its outlook. We only made marginal but positive estimate changes for the coming years after the report. We reiterate our EUR 10.00 target price and Reduce recommendation for Scanfil. We feel the short-term valuation of the share is neutral (2023:e P/E 14x, EV/EBIT 12x), although in the longer term, we believe Scanfil still offers a strong, profitable growth investment story.
